Key Events This Week
20 Jul: Stock opens at Rs.1,675.00, marginally up 0.54%
23 Jul: Price surges to Rs.1,728.70 (+3.26%) on technical upgrade
24 Jul: MarketsMOJO upgrades CARE Ratings to Buy on strong fundamentals
24 Jul: Week closes at Rs.1,680.10, up 0.85% vs Sensex down 1.85%
Monday, 20 July 2026: Steady Start Amid Flat Market
CARE Ratings began the week at Rs.1,675.00, gaining 0.54% on the day, while the Sensex remained essentially flat, closing at 36,504.94 with a negligible decline of 0.00%. The stock’s volume was moderate at 580 shares, reflecting cautious investor positioning ahead of anticipated developments later in the week.
Tuesday, 21 July 2026: Minor Pullback Despite Sensex Gains
The stock slipped 0.38% to Rs.1,668.60 on increased volume of 931 shares, contrasting with a slight Sensex gain of 0.04%. This minor correction appeared to be a consolidation phase following Monday’s modest advance, with investors awaiting clearer signals from technical and fundamental catalysts.
Wednesday, 22 July 2026: Recovery on Weak Market Sentiment
CARE Ratings rebounded by 0.33% to Rs.1,674.15, supported by a surge in volume to 1,584 shares. This recovery came despite a sharp Sensex decline of 0.88%, indicating relative strength in the stock. The price action suggested growing investor interest ahead of the technical upgrade and rating announcement expected later in the week.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Thursday, 23 July 2026: Technical Momentum Spurs Sharp Rally
The stock surged 3.26% to close at Rs.1,728.70 on heavy volume of 3,232 shares, marking the week’s high. This rally was driven by a notable shift in technical momentum, with MarketsMOJO upgrading CARE Ratings’ technical grade from mildly bullish to bullish. Key indicators such as the weekly MACD, Bollinger Bands, and On-Balance Volume confirmed strong buying interest. The stock’s relative strength was evident as the Sensex declined 0.70% on the same day.
Friday, 24 July 2026: Upgrade to Buy Rating Supports Price Stability
CARE Ratings closed the week at Rs.1,680.10, down 2.81% on the day but still posting a weekly gain of 0.85%. The volume remained elevated at 2,186 shares. The MarketsMOJO upgrade to a Buy rating was announced on this day, reflecting strong financial results including a 28.77% quarter-on-quarter rise in Profit Before Tax and a net-debt free balance sheet. Despite the day’s price dip, the upgrade signals renewed investor confidence amid a weak Sensex environment, which fell 0.32% on the day and 1.85% for the week.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-20 | Rs.1,675.00 | +0.54% | 36,504.94 | -0.00% |
| 2026-07-21 | Rs.1,668.60 | -0.38% | 36,518.28 | +0.04% |
| 2026-07-22 | Rs.1,674.15 | +0.33% | 36,196.43 | -0.88% |
| 2026-07-23 | Rs.1,728.70 | +3.26% | 35,944.66 | -0.70% |
| 2026-07-24 | Rs.1,680.10 | -2.81% | 35,829.46 | -0.32% |
Key Takeaways from the Week
Positive Signals: CARE Ratings demonstrated resilience by outperforming the Sensex, which declined 1.85% over the week. The MarketsMOJO upgrade to a Buy rating on 24 July was supported by strong quarterly financials, including a 28.77% increase in Profit Before Tax and a net-debt free balance sheet. Technical indicators such as MACD, Bollinger Bands, and On-Balance Volume shifted decisively bullish, underpinning the stock’s upward momentum. Institutional holding remains robust at 54.99%, signalling confidence from well-informed investors.
Cautionary Notes: Despite the upgrade and positive momentum, the stock trades at a premium valuation with a Price to Book ratio of 5.6 and a PEG ratio of 1.3, suggesting fair to expensive pricing relative to earnings growth. Some monthly technical indicators, including the MACD and Know Sure Thing oscillator, remain mildly bearish, indicating potential consolidation or volatility in the medium term. The stock’s long-term growth rate is moderate, with net sales growing at 13.75% annually, which may temper expectations for rapid appreciation.
Thinking about CARE Ratings Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Conclusion: Balanced Optimism Amid Market Headwinds
CARE Ratings Ltd’s performance this week reflects a cautious but positive shift in investor sentiment. The stock’s 0.85% weekly gain amid a declining Sensex highlights its relative strength, supported by a technical momentum upgrade and robust financial results. The MarketsMOJO Buy rating upgrade reinforces confidence in the company’s operational consistency and net-debt free status. However, investors should remain mindful of the premium valuation and mixed longer-term technical signals that suggest potential volatility ahead.
Overall, CARE Ratings appears well-positioned to maintain its upward trajectory in the near term, benefiting from strong institutional backing and improving technical indicators. Continued monitoring of valuation metrics and broader market conditions will be essential to assess the sustainability of this momentum.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
